JP2017529868A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2017529868A5 JP2017529868A5 JP2017518842A JP2017518842A JP2017529868A5 JP 2017529868 A5 JP2017529868 A5 JP 2017529868A5 JP 2017518842 A JP2017518842 A JP 2017518842A JP 2017518842 A JP2017518842 A JP 2017518842A JP 2017529868 A5 JP2017529868 A5 JP 2017529868A5
- Authority
- JP
- Japan
- Prior art keywords
- phage
- target
- region
- host
- bacteriophage
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Images
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB1417810.7 | 2014-10-08 | ||
| GBGB1417810.7A GB201417810D0 (en) | 2014-10-08 | 2014-10-08 | Modifying bacteriophage |
| PCT/EP2015/073296 WO2016055586A1 (en) | 2014-10-08 | 2015-10-08 | Modifying bacteriophage |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2017529868A JP2017529868A (ja) | 2017-10-12 |
| JP2017529868A5 true JP2017529868A5 (enExample) | 2019-04-11 |
| JP6748074B2 JP6748074B2 (ja) | 2020-08-26 |
Family
ID=51947056
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017518842A Active JP6748074B2 (ja) | 2014-10-08 | 2015-10-08 | バクテリオファージの改変 |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US10953052B2 (enExample) |
| EP (1) | EP3201323B1 (enExample) |
| JP (1) | JP6748074B2 (enExample) |
| AU (1) | AU2015329959B2 (enExample) |
| CA (1) | CA2963690A1 (enExample) |
| DK (1) | DK3201323T3 (enExample) |
| ES (1) | ES2768773T3 (enExample) |
| GB (1) | GB201417810D0 (enExample) |
| HR (1) | HRP20200171T1 (enExample) |
| HU (1) | HUE047552T2 (enExample) |
| LT (1) | LT3201323T (enExample) |
| PL (1) | PL3201323T3 (enExample) |
| PT (1) | PT3201323T (enExample) |
| SI (1) | SI3201323T1 (enExample) |
| WO (1) | WO2016055586A1 (enExample) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB201417810D0 (en) | 2014-10-08 | 2014-11-19 | Phico Therapeutics Ltd | Modifying bacteriophage |
| GB2544957B (en) * | 2015-07-15 | 2020-05-27 | Phico Therapeutics Ltd | Modifying bacteriophage |
| ES2867029T3 (es) * | 2016-04-08 | 2021-10-20 | Phico Therapeutics Ltd | Bacteriófago modificado |
| EP3440204A1 (en) | 2016-04-08 | 2019-02-13 | Phico Therapeutics Ltd | Modifying bacteriophage |
| WO2018002940A1 (en) * | 2016-06-30 | 2018-01-04 | Technology Innovation Momentum Fund (Israel) Limited Partnership | Bacteriophage variants having extended host-range, methods for preparation and uses thereof in transducing nucleic acids into hosts of interest |
| CA3219077A1 (en) * | 2021-05-12 | 2022-11-17 | Eligo Bioscience | Production of lytic phages |
| EP4499820A1 (en) | 2022-03-30 | 2025-02-05 | Hun-Ren Biological Research Centre Szeged | Metagenomic libraries |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2417188A1 (en) | 2000-07-25 | 2002-01-31 | Carl R. Merril | Bacteriophage having multiple host range |
| GB0028130D0 (en) | 2000-11-17 | 2001-01-03 | Phico Therapeutics Ltd | Polypeptide and uses thereof |
| AU2003220072A1 (en) | 2002-03-06 | 2003-09-22 | Musc Foundation For Research Development | Genetically engineered phage and the use of genetically engineered phage to deliver nucleic acid to bacteria |
| GB0314469D0 (en) * | 2003-06-20 | 2003-07-23 | Phico Therapeutics Ltd | Antimicrobial compositions and uses thereof |
| US7244612B2 (en) * | 2004-10-07 | 2007-07-17 | University Of Wyoming | Template reporter bacteriophage platform and multiple bacterial detection assays based thereon |
| GB0715416D0 (en) * | 2007-08-07 | 2007-09-19 | Phico Therapeutics Ltd | Modified bacteriophage |
| WO2009055697A1 (en) * | 2007-10-24 | 2009-04-30 | The Texas A & M University System | Chimeric phage tail proteins and uses thereof |
| GB201417810D0 (en) | 2014-10-08 | 2014-11-19 | Phico Therapeutics Ltd | Modifying bacteriophage |
-
2014
- 2014-10-08 GB GBGB1417810.7A patent/GB201417810D0/en not_active Ceased
-
2015
- 2015-10-08 US US15/517,732 patent/US10953052B2/en active Active
- 2015-10-08 HU HUE15775457A patent/HUE047552T2/hu unknown
- 2015-10-08 DK DK15775457.3T patent/DK3201323T3/da active
- 2015-10-08 JP JP2017518842A patent/JP6748074B2/ja active Active
- 2015-10-08 AU AU2015329959A patent/AU2015329959B2/en active Active
- 2015-10-08 PT PT157754573T patent/PT3201323T/pt unknown
- 2015-10-08 HR HRP20200171TT patent/HRP20200171T1/hr unknown
- 2015-10-08 ES ES15775457T patent/ES2768773T3/es active Active
- 2015-10-08 LT LTEP15775457.3T patent/LT3201323T/lt unknown
- 2015-10-08 CA CA2963690A patent/CA2963690A1/en active Pending
- 2015-10-08 SI SI201531088T patent/SI3201323T1/sl unknown
- 2015-10-08 PL PL15775457T patent/PL3201323T3/pl unknown
- 2015-10-08 EP EP15775457.3A patent/EP3201323B1/en active Active
- 2015-10-08 WO PCT/EP2015/073296 patent/WO2016055586A1/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2017529868A5 (enExample) | ||
| US11530405B2 (en) | Anti-CRISPR genes and proteins and methods of use | |
| Wettstadt et al. | Delivery of the Pseudomonas aeruginosa phospholipase effectors PldA and PldB in a VgrG-and H2-T6SS-dependent manner | |
| JP2014504851A5 (enExample) | ||
| JP2019214579A5 (enExample) | ||
| JP2022058377A (ja) | 異なる尾繊維を有する複数宿主域のバクテリオファージ | |
| WO2017015652A1 (en) | Bacteriophage for treating staphylococcus infections | |
| JP2022058378A (ja) | 異なる尾繊維を有する複数宿主域のバクテリオファージ | |
| GB2612491A (en) | Design of bacteriophage-based artificial viruses for human genome remodeling | |
| MY209964A (en) | Isolated modified vp1 capsid protein of aav5 | |
| JP2017529868A (ja) | バクテリオファージの改変 | |
| MX2023001219A (es) | Constructos de vacuna y sus usos contra infecciones causadas por staphylococcus. | |
| CN117120621A (zh) | 提高效率和准确性的基因组编辑 | |
| KR101641578B1 (ko) | 프로모터 변이체 및 이를 이용한 단백질 생산방법 | |
| KR101280503B1 (ko) | 프로모터 변이체 및 이를 이용한 단백질 생산방법 | |
| Ishag et al. | A replicating plasmid-based vector for GFP expression in Mycoplasma hyopneumoniae | |
| CN102120760A (zh) | 一种来源于噬菌体的抗菌肽及其应用 | |
| Moghadaszadeh et al. | OJVRTM | |
| US20170183642A1 (en) | Paenibacillus larvae treatment with phage lysin for american foulbrood disease | |
| NO20085201L (no) | Rekombinante novirhabdoviruser og deres anvendelse | |
| US10704051B2 (en) | Expression element, expression cassette, and vector containing the same | |
| JP7782793B2 (ja) | キュウリモザイクウイルス基盤改良型組換えベクター | |
| US20240148806A1 (en) | Bacteriophages producing heterologous bacteriocins | |
| JP2020005600A (ja) | 新規組換えバクテリオファージ | |
| JP2025508723A (ja) | 細菌を操作するためのシステム、ツール、及び方法 |